Advertisement
Advertisement

Activist Cevian Takes 5% Stake in British Insurer Aviva

By:
Reuters
Updated: Jun 8, 2021, 07:26 UTC

LONDON (Reuters) - Activist investor Cevian Capital said on Tuesday it had built up a 4.95% stake in Aviva and that the British insurer should be able to return 5 billion pounds ($7.08 billion) of excess capital in 2022.

FILE PHOTO: The Aviva logo sits outside the company head

“Aviva has been poorly managed for many years, and its high-quality core businesses have been held back by high costs and a series of bad strategic decisions,” Christer Gardell, managing partner and co-founder of Cevian said in a statement.

Aviva should have a value of more than eight pounds per share within three years, and more than double its dividend to 45 pence, Cevian said.

Aviva’s shares are currently trading a little over four pounds a share.

Aviva said last month it had raised 7.5 billion pounds from recent disposals and planned to return money to shareholders, without putting a figure on it.

Analysts have said the insurer would have between 3.7 and 6.6 billion pounds of excess capital following the completion of the asset sales.

“Aviva has made significant strategic progress over the past eleven months and we remain sharply focused on further improving our performance,” an Aviva spokesperson said in an emailed statement.

“We regularly engage with investors and welcome any thoughts which move us towards our goal of delivering long term shareholder value”.

($1 = 0.7063 pounds)

(Reporting by Carolyn Cohn; Editing by Rachel Armstrong)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement